Whole-Pelvic Versus Prostate-Only Radiation Therapy in Unfavorable Intermediate-Risk and High-Risk Prostate Cancer Treated with Androgen Deprivation Therapy and Brachytherapy Boost

被引：0
|
作者：
Yang, D. D. [1 ]
Mahal, B. A. [2 ]
Muralidhar, V. [3 ]
Martin, N. E. [4 ]
King, M. [5 ]
Mouw, K. [4 ]
Nguyen, P. L. [6 ,7 ]
Orio, P. F., III [8 ]
机构：
[1] Harvard Med Sch, Boston, MA USA
[2] Harvard Med Sch, Harvard Radiat Oncol Program, Boston, MA USA
[3] Harvard Radiat Oncol Program, Boston, MA USA
[4] Brigham & Womens Hosp, Dana Farber Canc Inst, 75 Francis St, Boston, MA 02115 USA
[5] Brigham & Womens Hosp, Dept Radiat Oncol, Dana Farber Canc Inst, 75 Francis St, Boston, MA 02115 USA
[6] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA
[7] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA
[8] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2018年 / 102卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SU_36_2351
引用
收藏
页码：E150 / E151
页数：2
相关论文
共 50 条
  • [1] Survival Outcomes in Men with Unfavorable Intermediate-Risk and High-Risk Prostate Cancer Treated with Prostate-Only versus Whole Pelvic Radiation Therapy
    Andruska, Neal
    Fischer-Valuck, Benjamin W.
    Waters, Michael
    Diaz, Elizabeth Juarez
    Agabalogun, Temitope
    Kim, Eric H.
    Smith, Zachary L.
    Brenneman, Randall J.
    Gay, Hiram A.
    Andriole, Gerald L.
    Michalski, Jeff M.
    Baumann, Brian C.
    JOURNAL OF UROLOGY, 2022, 207 (06): : 1227 - 1234
  • [2] Survival outcomes in men with unfavorable intermediate-risk and high-risk prostate cancer treated with prostate-only versus whole pelvic radiation therapy.
    Andruska, Neal
    Fischer-Valuck, Benjamin Walker
    Diaz, Elizabeth Juarez
    Agabalogun, Temitope
    Brenneman, Randall
    Gay, Hiram Alberto
    Michalski, Jeff M.
    Baumann, Brian C.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [3] Radiation therapy in high-risk and very high-risk localized or locally advanced prostate cancer Prostate-only versus prostate plus whole-pelvic?
    Stuschke, Martin
    Hadaschik, Boris
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (10) : 939 - 942
  • [4] Survival Outcomes of Whole-Pelvic Versus Prostate-Only Radiation Therapy for High-Risk Prostate Cancer Patients With Use of the National Cancer Data Base
    Amini, Arya
    Jones, Bernard L.
    Yeh, Norman
    Rusthoven, Chad G.
    Armstrong, Hirotatsu
    Kavanagh, Brian D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (05): : 1052 - 1063
  • [5] Whole-Pelvis Versus Prostate-Only Radiation Therapy and Androgen Deprivation Therapy: Effects on Mortality Risk
    Braunstein, L. Z.
    Chen, M. H.
    Dosoretz, D. E.
    Salenius, S.
    Katin, M.
    Nanda, A.
    D'Amico, A. V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E190 - E191
  • [6] Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial
    Murthy, Vedang
    Maitre, Priyamvada
    Kannan, Sadhana
    Panigrahi, Gitanjali
    Krishnatry, Rahul
    Bakshi, Ganesh
    Prakash, Gagan
    Pal, Mahendra
    Menon, Santosh
    Phurailatpam, Reena
    Mokal, Smruti
    Chaurasiya, Dipika
    Popat, Palak
    Sable, Nilesh
    Agarwal, Archi
    Rangarajan, Venkatesh
    Joshi, Amit
    Noronha, Vanita
    Prabhash, Kumar
    Mahantshetty, Umesh
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (11) : 1234 - +
  • [7] INTERMEDIATE-RISK PROSTATE CANCER, ANDROGEN DEPRIVATION THERAPY AND THE RISK OF DEATH
    Pickles, Tom
    Tyldesley, Scott
    Keyes, Mira
    Morris, W. James
    RADIOTHERAPY AND ONCOLOGY, 2016, 120 : S27 - S27
  • [8] Neoadjuvant versus concurrent androgen deprivation therapy plus radiotherapy for unfavorable intermediate-risk and high-risk prostate cancer with low PSA.
    Andruska, Neal
    Agabalogun, Temitope
    Fischer-Valuck, Benjamin Walker
    Brenneman, Randall
    Gay, Hiram Alberto
    Michalski, Jeff M.
    Baumann, Brian Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [9] Prostate-Specific Antigen Kinetics After Hypofractionated Stereotactic Body Radiation Therapy Boost and Whole-Pelvic Radiation Therapy for Intermediate- and High-Risk Prostate Cancer
    Kim, H. J.
    Kim, W. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E286 - E286
  • [10] Brachytherapy for Intermediate-Risk Prostate Cancer, Androgen Deprivation, and the Risk of Death
    Pickles, Tom
    Tyldesley, Scott
    Hamm, Jeremy
    Virani, Sean A.
    Morris, W. James
    Keyes, Mira
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (01): : 45 - 52
12345